3M reported a strong first quarter with record EPS and robust sales growth across multiple segments, including significant performance in emerging markets and healthcare. Despite challenges from the Japan earthquake and slight margin pressure due to raw material costs, management raised their full-year guidance and highlighted strategic growth initiatives. These positive results and outlook are likely to bolster investor confidence in the short term.

[1]